Hence, in clinical diagnosis and treatment, serum marker tests for A2M, LBP, CTSG, CST3, and FABP1 should be prioritized in patients with a high suspicion of stroke for early detection and timely intervention. This evidence concerns the gene LBP and stroke disorder.